SCHEMBL3720328

SCHEMBL3720328

Cc1nn(C)c(C)c1-c1ccccc1C#N

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CREBBP Q92793 1/20 0.45
HTR1A P08908 1/20 0.43
CHRM5 P08912 1/20 0.43
ADRA2A P08913 1/20 0.43
ADRA2B P18089 1/20 0.43
HTR1D P28221 1/20 0.43
HTR1B P28222 1/20 0.43
HTR7 P34969 1/20 0.43
HTR3A P46098 1/20 0.43
HTR5A P47898 1/20 0.43
TMEM97 Q5BJF2 1/20 0.43
SIGMAR1 Q99720 1/20 0.43
HPGD P15428 1/20 0.43
TSHR P16473 1/20 0.40
MAPT P10636 1/20 0.39
BRD4 O60885 3/20 0.39
KDM4E B2RXH2 3/20 0.39
POLB P06746 2/20 0.39
ALDH1A1 P00352 1/20 0.39
DHODH Q02127 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14559946 0.79 KDM4E (0.46) HPGDTSHRMAPTKDM4EALDH1A1
SCHEMBL111791 0.72 CDK4 (0.48) HPGDMAPTKDM4EPOLBALDH1A1
SCHEMBL1132593 0.70 TSHR (0.61) HTR1AHTR7HPGDTSHRKDM4E
SCHEMBL20320421 0.70 MAPT (0.67) CREBBPHTR1AHTR7HPGDMAPT
SCHEMBL111483 0.69 CHEK1 (0.51) HPGDTSHRMAPTBRD4KDM4E
SCHEMBL18812499 0.69 BRD4 (0.51) TSHRBRD4ALDH1A1ESR2
SCHEMBL3716370 0.69 POLB (0.51) CREBBPHTR1ACHRM5ADRA2AADRA2B
SCHEMBL1233435 0.69 USP8 (0.35) CREBBPHPGDTSHRMAPTKDM4E
SCHEMBL27909137 0.68 ESR2 (0.52) TSHRKDM4EALDH1A1ESR2GABRG2
SCHEMBL2186547 0.68 TSHR (0.59) HTR1AHTR7TSHRKDM4EESR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010125402-A1 IMIDAZOLE DERIVATIVES AND THEIR USE AS MODULATORS OF CYCLIN DEPENDENT KINASES NOVARTIS AG (CH) 2010-11-04 WO disclosed